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The G-protein Gsa exists in three isoforms, the Gsa splice variants Gsashort (GsaS) and Gsalong (GsaL), and the G-protein Gaolf that is not
only involved in olfactory signaling but also in extrapyramidal motor regulation. Studies with h2-adrenoceptor (h2AR)-Gsa fusion proteins
showed that Gsa proteins activate adenylyl cyclase (AC) in the order of efficacy GsaS>GsaLfGaolf and that Gsa proteins confer the
hallmarks of constitutive activity to the h2AR in the order of efficacy GsaL>Gaolf>GsaS. However, it is unclear whether such differences
between Gsa proteins also exist in the nonfused state. In the present study, we co-expressed the h2AR and dopamine D1-receptor (D1R) with
Gsa proteins at different ratios in Sf9 insect cells. In agreement with the fusion protein studies, nonfused Gaolf was less efficient than
nonfused GsaS and GsaL at activating AC, but otherwise, we did not observe differences between the three Gsa isoforms. Thus, it is much
easier to dissect differences between Gsa isoforms using h2AR-Gsa fusion proteins than nonfused Gsa isoforms.
D 2003 Elsevier B.V. All rights reserved.Keywords: Adenylyl cyclase; h2-adrenoceptor; Dopamine D1-receptor; Gsa splice variant; Gaolf; Sf9 insect cell1. Introduction
G-proteins are heterotrimeric membrane-bound proteins
that mediate signal transfer from receptors to cellular
effectors [1–3]. Upon binding of agonist to receptors,
receptors undergo a conformational change, allowing them
to promote the dissociation of GDP from Ga. GDP disso-
ciation from Ga is the rate-limiting step of the G-protein
cycle. Agonist-occupied receptors then form a ternary0005-2736/03/$ - see front matter D 2003 Elsevier B.V. All rights reserved.
doi:10.1016/S0005-2736(03)00174-3
Abbreviations: AC, adenylyl cyclase; h2AR, h2-adrenoceptor; h2AR-
Gaolf, fusion protein consisting of the h2-adrenoceptor and the G-protein
Gaolf; h2AR-GsaS, fusion protein consisting of the h2-adrenoceptor and the
short splice variant of Gsa; h2AR-GsaL, fusion protein consisting of the h2-
adrenoceptor and the long splice variant of Gsa; D1R, dopamine D1-
receptor; Gaolf, a Gsa protein that is not only involved in olfactory signal
transduction but also in extrapyramidal motor regulation; GsaS, short splice
variant of Gsa; GsaL, long splice variant of Gsa; GTPgS, guanosine 5V-O-(3-
thiotriphosphate); ICI 118,551, [erythro-DL-1(7-methylindan-4-yloxy)-3-
isopropylaminobutan-2-ol]; SCH 23390, 7-chloro-8-hydroxy-3-methyl-5-
phenyl-2,3,4,5-tetrahydro-1 H-3-benzazepine; SP followed by a three-digit
number, a specific Sf9 cell membrane preparation of our consecutively
labeled membrane inventory
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E-mail address: rseifert@ku.edu (R. Seifert).complex with the nucleotide-free G-protein that exhibits
high agonist-affinity. Subsequent GTP binding to Ga dis-
rupts the ternary complex and the G-protein dissociates into
Ga-GTP and the hg-complex. Both Ga-GTP and hg can
regulate the activity of effector systems. G-protein deacti-
vation is accomplished by the GTPase of Ga, cleaving GTP
into GDP and Pi. Subsequently, Ga-GDP and the hg-complex
reassociate, closing the G-protein cycle. Commonly em-
ployed methods for the analysis of the G-protein cycle are
the measurements of (i) ternary complex formation, (ii)
binding of the GTPase-resistant GTP analog GTPgS, (iii)
effector activity and (iv) steady-state GTP hydrolysis.
The G-protein Gsa mediates signal transfer from numer-
ous receptors including the h2-adrenoceptor (h2AR) and
dopamine D1-receptor (D1R) to adenylyl cyclase (AC) [1–
3]. There are three Gsa isoforms: Gaolf and the Gsa splice
variants GsaS and GsaL [4–8]. Gsa proteins are differentially
expressed in various organs including heart, liver and brain,
and Gsa isoform expression changes during development
and aging [9–19]. Additionally, Gsa expression changes in
various pathological conditions [20–25]. Moreover, the
phenotype of the Gaolf knockout mouse points to a specific
role of Gaolf in olfactory signal transduction and extrapyra-
midal motor regulation [26]. Collectively, all these data
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of the individual Gsa proteins.
However, it has been difficult to answer the question
whether biochemical differences between the three Gsa
proteins exist. Subtle differences in the interaction of the
h2AR with Gsa splice variants were observed in some but
not all studies [4,27–29]. Similar inconsistencies were
reported with respect to the efficacy of Gsa splice variants
at activating AC [27–30]. A problem in some of the
previous studies using mammalian expression systems was
to achieve comparable expression levels of the Gsa proteins
and receptor/Gsa stoichiometries [28,29].
In recent studies, we took advantage of the receptor-Ga
fusion protein technique to analyze the biochemical proper-
ties of GsaS, GsaL and Gaolf. In fusion proteins, the receptor
C-terminus is linked to the Ga N-terminus [31,32]. Com-
pared to conventional co-expression systems, signaling effi-
ciency is enhanced in fusion proteins [31,32]. Presumably,
the enhanced signaling efficiency in fusion proteins is due to
tight tethering of Gsa to the plasma membrane [33]. The
enhanced signaling efficiency facilitated comparison of
receptor-coupling to various Ga proteins [34–36]. When
expressed at comparable levels in Sf9 insect cells, h2AR-Gsa
fusion proteins activate AC in the order of efficacy h2AR-
GsaS>h2AR-GsaLfh2AR-Gaolf [34,37–39]. Moreover,
Gsa proteins confer to the h2AR the hallmarks of constitutive
(agonist-independent) activity in the order of efficacy
GsaL>Gaolf>GsaS [34,37]. However, fusion proteins do not
occur naturally, and one may question the physiological
relevance of the results obtained with fusion proteins
[31,32,40].
The critique regarding the fusion protein technique
prompted us to reexamine the question whether biochemical
differences between the three Gsa proteins in the nonfused
state can be unmasked. To address the question we analyzed
ternary complex formation, GTPgS binding, GTP hydroly-
sis and AC activity in Sf9 insect cell membranes co-
expressing the h2AR with GsaS, GsaL and Gaolf at different
G-protein/receptor ratios and compared the data with those
obtained for h2AR-Gsa fusion proteins. We also included
the D1R into our present study since this receptor may
specifically couple to Gaolf in the basal ganglia of the brain
[25,41].2. Materials and methods
2.1. Materials
Rat Gaolf cDNA in pBluescript KS [8] was kindly
provided by Dr. R.R. Reed (Howard Hughes Medical
Institute, Johns Hopkins University, Baltimore, MD,
USA). Baculovirus encoding the human D1R was kindly
provided by Dr. M. Bouvier (Department of Biochemistry,
University of Montreal, Quebec, Canada). Baculovirus
encoding GsaS was provided by Dr. A.G. Gilman (Depart-ment of Pharmacology, University of Texas Southwestern
Medical Center, Dallas, TX, USA). [a-32P]ATP (3000 Ci/
mmol), [g-32P]GTP (6000 Ci/mmol), [35S]GTPgS (1100 Ci/
mmol), [3H]dihydroalprenolol (110 Ci/mmol) and [3H]SCH
23390 (75 Ci/mmol) were from Perkin Elmer (Boston, MA,
USA). Adenylyl imididiphosphate, GDP, GTP, GTPgS and
ATP (special quality, catalogue #519,979; < 0.01% (wt/wt)
GTP contamination as assessed by HPLC analysis) were
obtained from Roche Diagnostics (Indianapolis, IN, USA).
ICI 118,551 was from RBI (Natick, MA, USA). Chlorprom-
azine, dopamine, ( )-isoproterenol and (F )-alprenolol
were from Sigma (St. Louis, MO, USA). All restriction
enzymes, DNA polymerase Klenov fragment A and T4
DNA ligase were from New England Biolabs (Beverly,
MA, USA). Glass fiber filters (GF/C) were from Schleicher
and Schuell (Dassel, Germany). The anti-Gsa Ig (C-termi-
nal) was from Calbiochem (La Jolla, CA, USA). The anti-
Gsa Ig against an epitope in the a-helical domain of GsaS/L
(K-20) and the anti-Gaolf Ig against an epitope in the a-
helical domain of Gaolf (K-19) [8] were from Santa Cruz
Biochemicals (Santa Cruz, CA, USA).
2.2. Generation of recombinant baculoviruses, cell culture
and membrane preparation
The generation of baculoviruses encoding h2AR, GsaL,
h2AR-GsaL, h2AR-GsaS and h2AR-Gaolf was described
previously [34,37,42]. For generation of a baculovirus
encoding Gaolf, pBluescript KS-Gaolf was digested with
EcoRI and BsrGI, and the overlapping fragments were filled
with DNA polymerase Klenov fragment A. This DNA
fragment was then digested with EcoNI and cloned into
the baculovirus expression vector pVL1392-h2AR-Gia2 that
had been opened with SacI, filled with DNA polymerase
Klenov fragment A and further digested with EcoNI. Re-
combinant baculoviruses were generated in Sf9 cells using
the BaculoGOLD transfection kit (Pharmingen) according to
the manufacturer’s instructions. Sf9 cells were cultured in
250-ml disposable Erlenmeyer flasks at 28 jC under rotation
at 125 rpm in SF 900 II medium (Invitrogen, Carlsbad, CA,
USA) supplemented with 5% (vol/vol) fetal calf serum (Bio
Whittaker, Walkersville, MD, USA) and 0.1 mg/ml genta-
micin (Bio Whittaker). Cells were maintained at a density of
0.5–6.0 106 cells/ml. After initial transfection, virus work
stocks were generated by two sequential virus amplifica-
tions. In the first amplification, cells were seeded at 2.0 106
cells/ml and infected with a 1:100 dilution of the supernatant
from the initial transfection. Cells were cultured for 7 days,
resulting in the death of virtually the entire cell population.
The supernatant fluid of this infection was harvested and
stored under light protection at 4 jC. In a second amplifica-
tion, cells were seeded at 3.0 106 cells/ml and infected with
a 1:20 dilution of the supernatant from the initial amplifica-
tion. Cells were cultured for 48 h, and the supernatant fluid
was harvested. After the 48-h culture, the majority of cells
showed signs of infections (e.g., altered morphology, viral
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supernatant fluid from the second amplification was also
stored under light protection at 4 jC and was the routine
virus stock for membrane preparations. For infection, cells
were sedimented by centrifugation and resuspended in fresh
medium. Cells were seeded at 3.0 106 cells/ml and infected
with 1:100, 1:1000 or 1:10,000 dilutions of baculovirus work
stocks encoding h2AR, D1R, h2AR-Gsa fusion proteins or
Gsa proteins. Sf9 cells were cultured for 48 h before mem-
brane preparation. Sf9 membranes were prepared as de-
scribed [43]. Cells were disrupted with 25 strokes in a
Dounce homogenizer in a buffer consisting of 10 mM Tris/
HCl, pH 7.4 and 1 mM EDTA, 0.2 mM phenylmethylsul-
fonyl fluoride, 10 Ag/ml benzamidine and 10 Ag/ml leupeptin
as protease inhibitors. Nuclei and unbroken cells were
removed by centrifugation for 5 min at 500 g at 4 jC.
The supernatant fluid was centrifuged for 30 min at
40,000 g 4 jC. Membranes were suspended in binding
buffer (12.5 mMMgCl2, 1 mM EDTA and 75 mM Tris/HCl,
pH 7.4). Membranes were stored at  80 jC.
2.3. [3H]dihydroalprenolol and [3H]SCH 23390 binding
assays
Membranes were thawed and sedimented by a 12-min
centrifugation at 4 jC and 15,000 g to remove residual
endogenous guanine nucleotides as far as possible and
resuspended in binding buffer. Expression levels of h2AR
and h2AR-Gsa fusion proteins were determined by incubat-
ing Sf9 membranes (10–30 Ag protein/tube) in the presence
of 10 nM [3H]dihydroalprenolol and 0.05% (wt/vol) bovine
serum albumin. Nonspecific binding was determined in the
presence of 10 nM [3H]dihydroalprenolol plus 10 AM (F )-
alprenolol. The total volume of binding reactions was 500
Al. Incubations were conducted for 90 min at 25 jC and
shaking at 250 rpm. For determination of the agonist-
affinities of the h2AR, reaction mixtures contained Sf9
membranes (15–30 Ag protein/tube), 1 nM [3H]dihydroal-
prenolol and ( )-isoproterenol at various concentrations in
the absence or presence of GTPgS (10 AM). For determi-
nation of the Kd and Bmax values of [
3H]SCH 23390
binding, reaction mixtures contained Sf9 membranes
(2.5–20 Ag protein/tube), 0.1–10 nM [3H]SCH 23390 and
0.05% (wt/vol) bovine serum albumin. Nonspecific binding
was determined in the presence of 0.1–10 nM [3H]SCH
23390 plus 1 mM dopamine. For determination of the
agonist-affinities of the D1R, reaction mixtures contained
Sf9 membranes (15–30 Ag protein/tube), 1 nM [3H]SCH
23390 and dopamine at various concentrations in the
absence or presence of GTPgS (10 AM). Bound radioligand
was separated from free radioligand by filtration through
GF/C filters using a 48-well harvester (model M-48R,
Brandel, Gaithersburg, MD, USA), followed by three
washes with 2 ml of binding buffer (4 jC). Filter-bound
radioactivity was determined by liquid scintillation counting
using Cytoscint cocktail from ICN (Irvine, CA, USA).2.4. [35S]GTPcs binding assay
[35S]GTPgS binding was determined as described
[36,43]. Briefly, membranes were thawed and sedimented
by a 12-min centrifugation at 4 jC and 15,000 g to
remove residual endogenous guanine nucleotides as far as
possible and resuspended in binding buffer. Reaction mix-
tures (total volume 500 Al) contained Sf9 membranes (30–
50 Ag protein/tube) in binding buffer supplemented with
0.05% (wt/vol) BSA, 1.0 nM [35S]GTPgS, 9 nM unlabeled
GTPgS (to give a final GTPgS concentration of 10 nM) and
1 AM GDP. Previous studies showed that these conditions
are appropriate to determine [35S]GTPgS saturation binding
to Gsa proteins in Sf9 membranes [36,37]. Reaction mix-
tures additionally contained solvent (basal), inverse agonist
or agonist. Incubations were conducted for 90 min at 25 jC
and shaking at 250 rpm. Bound [35S]GTPgS was separated
from free [35S]GTPgS by filtration through GF/C filters,
followed by three washes with 2 ml of binding buffer (4
jC). Filter-bound radioactivity was determined by liquid
scintillation counting. Nonspecific [35S]GTPgS binding was
determined in the presence of 10 AM unlabeled GTPgS.
2.5. Steady-state GTPase activity assay
GTPase activity was determined as described [37].
Briefly, membranes were thawed, sedimented by a 12-
min centrifugation at 4 jC and 15,000 g to remove
residual endogenous guanine nucleotides as far as possible
and resuspended in 10 mM Tris/HCl, pH 7.4. Assay tubes
contained Sf9 membranes (10 Ag protein/tube), 1.0 mM
MgCl2, 0.1 mM EDTA, 0.1 mM ATP, 100 nM GTP, 1 mM
adenylyl imidodiphosphate, 5 mM creatine phosphate, 40
Ag of creatine kinase and 0.2% (wt/vol) BSA in 50 mM
Tris/HCl, pH 7.4. Reaction mixtures additionally contained
solvent (basal) or the appropriate agonists at a maximally
effective concentration. Reaction mixtures (80 Al) were
incubated for 3 min at 25 jC before the addition of 20 Al of
[g-32P]GTP (0.2–0.5 ACi/tube). All stock and work dilu-
tions of [g-32P]GTP were prepared in 20 mM Tris/HCl, pH
7.4. Reactions were conducted for 20 min at 25 jC.
Reactions were terminated by the addition of 900 Al of
slurry consisting of 5% (wt/vol) activated charcoal and 50
mM NaH2PO4, pH 2.0. Charcoal absorbs nucleotides but
not Pi. Charcoal-quenched reaction mixtures were centri-
fuged for 15 min at room temperature at 15,000 g. Seven
hundred microliters of the supernatant fluid of reaction
mixtures was removed, and 32Pi was determined by liquid
scintillation counting. Enzyme activities were corrected for
spontaneous degradation of [g-32P]GTP. Spontaneous
[g-32P]GTP degradation was determined in tubes contain-
ing all of the above described components plus a very high
concentration of unlabeled GTP (1 mM) that, by compe-
tition with [g-32P]GTP, prevents [g-32P]GTP hydrolysis by
enzymatic activities present in Sf9 membranes. Spontane-
ous [g-32P]GTP degradation was < 1% of the total amount
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solvent for [g-32P]GTP. The experimental conditions cho-
sen ensured that not more than 10% of the total amount of
[g-32P]GTP added was converted to 32Pi.
2.6. AC activity assay
Membranes were thawed and sedimented by a 12-min
centrifugation at 4 jC and 15,000 g to remove residual
endogenous guanine nucleotides as far as possible and
resuspended in binding buffer. Tubes contained Sf9 mem-
branes (15–50 Ag protein/tube) expressing various proteins,
5 mM MgCl2, 0.4 mM EDTA, 30 mM Tris/HCl, pH 7.4
and GTPgS or GTP at various concentrations in the
absence or presence of receptor ligands. Assay tubes con-
taining membranes and various additions in a total volume
of 30 Al were incubated for 3 min at 37 jC before initiating
reactions by the addition of 20 Al of reaction mixture
containing (final) [a-32P]ATP (1.0–1.5 ACi/tube) plus 40
AM unlabeled ATP, 2.7 mM mono(cyclohexyl)ammonium
phosphoenolpyruvate, 0.125 IU pyruvate kinase, 1 IU
myokinase and 0.1 mM cAMP. Reactions were conducted
for 20 min at 37 jC. Reactions were terminated by the
addition of 20 Al of 2.2 N HCl. Denatured protein was
sedimented by a 3-min centrifugation at 25 jC and
15,000 g. Sixty-five microliters of the supernatant fluid
was applied onto columns filled with 1.3 g of neutral
alumina (Sigma A-1522, super I, WN-6). [32P]cAMP was
separated from [a-32P]ATP by elution of [32P]cAMP with 4
ml of 0.1 M ammonium acetate, pH 7.0 [44]. Recovery of
[32P]cAMP was f 80%. Blank values were f 0.01% of
the total amount of [a-32P]ATP added. [32P]cAMP was
determined by liquid scintillation counting.
2.7. SDS polyacrylamide gel electrophoresis and immuno-
blot analysis
Membrane proteins were separated on SDS polyacryl-
amide gels containing 10% (wt/vol) acrylamide [37]. Pro-
teins were then transferred onto Immobilon-P transfer
membranes (Millipore, Bedford, MA) according to the
manufacturer’s instructions. Membranes were reacted with
anti-Gsa Ig (C-terminal) (1:1000) or with K-19 Ig or K-20 Ig
(1:100 each). Immunoreactive bands were visualized with
anti-rabbit IgG coupled to peroxidase, using o-dianisidine
and H2O2 as substrates. For quantification of Gsa proteins,
we used Sf9 membranes (25, 50, 75 and 100 Ag protein/
lane) expressing the appropriate h2AR-Gsa fusion protein at
a defined level ({3H}dihydroalprenolol saturation binding)
as standards [35,43]. For Gsa-expressing membranes, 25–
75 Ag of protein was loaded per gel. Gaolf was quantified
using the K-19 Ig. GsaS and GsaL were quantified using the
K-20 Ig. Immunoblots were scanned using a Molecular
Imager FX and evaluated with the Quantity One image
analysis software (version 4.3) (Bio-Rad, Hercules, CA,
USA).2.8. Miscellaneous
Protein was determined using the Bio-Rad DC protein
assay kit. Data shown in Figs. 2–5 were analyzed by
nonlinear regression using the Prism III program (Graph-
Pad, Prism, San Diego, CA, USA).
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3.1. Expression of Gsa proteins, D1R and b2AR in Sf9
membranes
Sf9 cells were infected with baculoviruses encoding
various h2AR-Gsa fusion proteins and nonfused Gsa pro-
teins, and the expression of proteins was analyzed by
immunoblotting. When expressed in mammalian cells, GsaS
and GsaL exhibit apparent molecular masses of 45 and 52
kDa, respectively [28–30]. In agreement with those data,
the anti-Gsa Ig (C-terminal) (Fig. 1A) and K-20 Ig (Fig. 1C)
recognized 45- and 52-kDa proteins in Sf9 membranes
expressing GsaS and GsaL, respectively. In membranes
expressing GsaL, the anti-Gsa Ig and K-20 Ig recognized a
proteolytic fragment of f 40 kDa that was also observed in
another study [45]. The C terminus of Gaolf differs from the
C terminus of GsaS/L only in one amino acid [8]. Therefore,
it was not surprising that the anti-Gsa Ig against the C
terminus of GsaS/L also recognized Gaolf (Fig. 1A). In
agreement with a previous expression study using S49 cyc 
lymphoma cells [28], Gaolf expressed in Sf9 membranes
exhibited a slightly higher molecular mass than GsaS. GsaS/L
and Gaolf differ significantly from each other in the a-helical
domain [8]. Accordingly, this domain is feasible for the
generation of Gsa subtype-specific antibodies [8]. Indeed,
the K-19 Ig against a specific epitope of the a-helical
domain of Gaolf strongly reacted with Gaolf and the
h2AR-Gaolf fusion protein expressed in Sf9 membranes
but not with Gsa splice variants or the h2AR-GsaL fusion
protein (Fig. 1B). In contrast, the GsaS/L-specific K-20 Ig
did not detect Gaolf and the h2AR-Gaolf fusion protein
(Fig. 1C).
For quantification of nonfused Gsa proteins in immuno-
blotting, we used h2AR-Gsa fusion proteins expressed at a
defined level ([3H]dihydroalprenolol saturation binding) as
standard. Fig. 1A and C illustrates a typical problem of
protein expression studies with Sf9 cells. Specifically, in the
initial phase of the project, we used identical dilutions
(1:100) of virus work stocks encoding Gsa proteins. It
emerged that GsaS was expressed at lower levels than GsaL
and Gaolf. Attempts to achieve identical Gsa expression
levels by titration of virus stocks were only partially
successful (Tables 1–4).
[3H]Dihydroalprenolol binding to the human h2AR
expressed in Sf9 membranes was characterized in a previous
study [43]. The human D1R expressed in Sf9 membranes
bound the antagonist radioligand [3H]SCH 23390 with a Kd
Fig. 1. Analysis of the expression of Gsa-proteins in Sf9 membranes. Sf9 cells were infected with the baculoviruses indicated below panels A–C, and incubated
for 48 h before membrane preparation. Sf9 cell membranes (50 Ag of protein/lane) were separated on SDS gels containing 10% (wt/vol) acrylamide as
described in Materials and methods. Proteins were transferred onto Immobilon-P transfer membranes and probed with anti-Gsa Ig (C-terminal (A), K-19 Ig
(anti-Gaolf) (B) or K-20 Ig (anti-Gsa) (C). The expression levels of fusion proteins were assessed by [
3H]dihydroalprenolol saturation binding (h2AR-GsaL, 7.0
pmol/mg; h2AR-Gaolf, 19.5 pmol/mg). Shown are the horseradish peroxidase-reacted Immobilon-P transfer membranes. Numbers on the left indicate molecular
masses of marker proteins.
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performed in triplicates). This Kd value fits well to the Kd
value for the D1R expressed in rat brain (0.7 nM) [46].
Depending on the baculovirus dilution used, the D1R was
expressed with Bmax values of 1.5–24.8 pmol/mg (Tables
1–4 and Fig. 5). These expression levels are comparable
with the expression levels obtained for the h2AR (0.9–24.0
pmol/mg, Tables 1–4 and Fig. 5).
3.2. Agonist binding properties of the D1R and b2AR
We studied ternary complex formation with the D1R and
h2AR indirectly by competing radioligand antagonist bind-
ing with unlabeled agonist in the absence and presence of
GTPgS. Figs. 2 and 3 show representative agonist compe-
tition curves for the D1R and h2AR co-expressed with the
three Gsa proteins at various G-protein/receptor ratios, and
Table 1 provides a summary of the nonlinear regression
analysis of the agonist competition curves. Table 1 also
contains the nonlinear regression analysis for additional
membrane preparations not shown in Figs. 2 and 3.
An increase in the G-protein/receptor ratio should facil-
itate detection of high-affinity agonist binding [47,48]. We
varied the Gaolf/receptor ratio between 0.3 and 5.9, the GsaS/
receptor between 0.4 and 2.1 and the GsaL/receptor ratio
between 0.7 and 11. In a previous study we reported that a
GsaL/h2AR ratio of f 100 allowed for the detection of
high-affinity agonist binding [43]. The data of our present
study show that a GsaL/h2AR ratio of f 10 is sufficient to
detect ternary complex formation. However, the data for the
h2AR/GsaL couple cannot be extrapolated to other receptor/
Gsa couples. Specifically, ternary complex formation was
detected in the membrane with the lowest GsaL/D1R ratio
(SP366, Fig. 2F), but not in the membrane with the highest
GsaL/D1R ratio (SP386, Fig. 2E). With respect to GsaS, inone membrane preparation with a G-protein/D1R ratio of 0.7
(SP474), no ternary complex formation was detected,
whereas in another preparation with the same G-protein/
receptor ratio (SP339), high-affinity binding was clearly
detected. Additionally, with several receptor/G-protein
pairs, an increase in the G-protein/receptor ratio by a factor
of f 2 did not result in an equivalent increase in high-
affinity agonist binding (D1R plus Gaolf, compare SP378
with SP384; h2AR plus GsaS, compare SP161 with SP410).
Moreover, even at GsaS/h2AR ratio as low as 0.4 (SP161),
ternary complex formation was detected. Taken together,
our data show that all Gsa proteins are capable of stabilizing
the ternary complex with the D1R and h2AR, indicating that
at least a fraction of the expressed Gsa proteins is functional.
However, there is no correlation between G-protein/receptor
ratio and ternary complex formation.
3.3. GTPcs binding studies
The measurement of ligand-regulated GTPgS saturation
binding provides a method to determine the number of G-
proteins activated by a given receptor [49,50]. As predicted
by the receptor/Ga stoichiometry, 1 mol of h2AR-Gsa fusion
protein binds f 1 mol of GTPgS [36,37]. A previous study
suggested that in nonfused systems, signal transfer between
receptors and G-proteins is catalytic, i.e. one receptor
molecule activates multiple G-proteins [49], but subsequent
studies rather suggested that signal transfer is linear or even
sublinear [35,36].
When using Sf9 cells as expression proteins for mam-
malian Gsa proteins, one has to keep in mind that the D1R
and h2AR can also couple to the Gsa-like proteins of the
insect cells, providing the background signaling activity
[42,51,52]. In membranes expressing the h2AR alone
(SP46), the ligand-regulated increase in GTPgS binding
Fig. 2. Competition of [3H]SCH 23390 binding by dopamine in Sf9 membranes expressing the D1R and various Gsa proteins. [
3H]SCH 23390 binding in Sf9
membranes was determined as described in Materials and methods. Reaction mixtures contained membranes expressing the proteins indicated in panels A–F, 1
nM [3H]SCH 23390 and dopamine at increasing concentrations. Tubes additionally contained solvent (control) (o) or GTPgS (10 AM) (.). Data points are the
meansF S.D. of three to four experiments performed in triplicates. Data were analyzed for best fit to monophasic or biphasic competition isotherms. The
results of the nonlinear regression analysis and the receptor- and Gsa expression levels of the various membrane preparations are summarized in Table 1.
‘‘ 11’’ designates the absence of dopamine.
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responding to 0.015 activated G-protein molecules per
h2AR molecule (Table 2). Thus, only a very small fraction
of the expressed h2AR molecules actually couples to the
Gsa-like proteins of the insect cells. The latter number is
also referred to as coupling factor [35,36]. In membranes
expressing the D1R and h2AR with Gsa proteins, ligand-
regulated GTPgS binding did not generally exceed the
values observed for membranes expressing receptor alone
(Table 2). In no case, ligand-regulated GTPgS binding in the
co-expression membranes approached the values observed
for h2AR-Gsa fusion proteins, i.e. the coupling factorsreached f 0.24 at best. When expressed as the percentage
of Gsa proteins activated, the highest values were generally
observed for GsaS (up to 11%). Thus, only a small fraction
of the expressed Gsa proteins participated in receptor-
regulated GDP/GTPgS exchange.
3.4. GTPase studies
The steady-state GTPase assay measures the outcome of
multiple G-protein cycles and can be readily applied to Sf9
membranes since this system possesses a very low basal
GTPase activity, providing an excellent signal-to noise ratio
Fig. 3. Competition of [3H]dihydroalprenolol binding by ( )-isoproterenol in Sf9 membranes expressing the h2AR and various Gsa proteins.
[3H]Dihydroalprenolol binding in Sf9 membranes was determined as described in Materials and methods. Reaction mixtures contained membranes expressing
the proteins indicated in panels A–F, 1 nM [3H]dihydroalprenolol and ( )-isoproterenol at increasing concentrations. Tubes additionally contained solvent
(control) (o) or GTPgS (10 AM) (.). Data points are the meansF S.D. of three to four experiments performed in triplicates. Data were analyzed for best fit to
monophasic or biphasic competition isotherms. The results of the nonlinear regression analysis and the receptor- and Gsa expression levels of the various
membrane preparations are summarized in Table 1. ‘‘ 11’’ designates the absence of ( )-isoproterenol.
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( )-isoproterenol increased GTP hydrolysis by 0.30 pmol/
mg/min (Table 3). In Sf9 membranes expressing the D1R or
h2AR plus Gsa proteins, the absolute increases in agonist-
stimulated GTP hydrolysis were not consistently larger than
in membranes expressing receptor alone.
3.5. Analysis of AC activity in the absence of receptors
In membranes from uninfected Sf9 cells, GTPgS stimu-
lated AC with an EC50 of f 40 nM (95% confidenceinterval, 17–112 nM) and a maximum activity of 5.9
pmol/mg/min (95% confidence interval, 5.2–6.7 pmol/mg/
min) (Fig. 4A). This AC activation represents the back-
ground mediated by the endogenous Gsa-like proteins of Sf9
cells. In membranes expressing Gaolf, GTPgS activated AC
with similar potency (EC50, 36 nM; 95% confidence inter-
val, 20–62 nM) as in membranes from uninfected Sf9 cells,
but the maximum AC activity achieved with Gaolf was only
moderately higher (10.4 pmol/mg/min; 95% confidence
interval, 9.6–11.1 pmol/mg/min) than in membranes from
uninfected cells (Fig. 4B). In membranes expressing GsaS or
Table 1
Nonlinear regression analysis of the agonist binding properties of the D1R and h2AR in Sf9 membranes co-expressed with various Gsa proteins at different G-
protein/receptor ratios
Constructs (receptor
level in pmol/mg)
Gsa (pmol/mg) G/R ratio Membrane
preparation
Kh (nM) Kl (AM) Rh (%) KGTPgS (AM)
D1R+Gaolf
19.9 7.5 0.3 SP364 – 2.1 (1.4–3.2) – 2.0 (1.4–3.0)
7.8 8.1 1.0 SP378 27 (5.0–150) 1.5 (1.1–2.0) 12 (2–25) 1.1 (0.9–1.4)
4.9 10.5 2.1 SP384 0.2 (0.01–5.6) 0.6 (0.5–0.7) 6 (2–11) 0.6 (0.5–0.8)
1.5 8.9 5.9 SP395 14 (7.0–27) 0.5 (0.3–1.0) 47 (33–60) 0.3 (0.3–0.4)
D1R+GsaS
13.5 8.8 0.7 SP474 – 1.1 (0.8–1.6) – 1.1 (0.7–1.7)
11.8 10.5 0.9 SP475 3.0 (0.3–19) 0.7 (0.5–1.1) 16 (9–24) 0.5 (0.3–0.8)
6.3 11.9 1.9 SP476 1.3 (0.2–8.8) 0.7 (0.4–1.2) 25 (20–29) 0.6 (0.5–0.7)
5.7 4.0 0.7 SP339 0.4 (0.1–4.5) 0.6 (0.4–0.8) 15 (10–20) 0.6 (0.5–0.8)
D1R+GsaL
10.9 10.7 1.0 SP366 0.8 (0.1–4.8) 0.9 (0.8–1.1) 9 (5–12) 0.9 (0.7–1.1)
3.8 11.5 3.0 SP380 – 0.5 (0.3–0.7) – 0.7 (0.5–0.9)
2.2 11.5 5.2 SP386 – 0.7 (0.4–1.0) – 0.6 (0.4–0.9)
h2AR+Gaolf
24.0 6.1 0.3 SP426 – 0.3 (0.2–0.4) – 0.3 (0.2–0.3)
17.5 6.5 0.4 SP367 – 0.3 (0.2–0.4) – 0.4 (0.3–0.5)
17.1 6.8 0.4 SP409 – 0.3 (0.2–0.4) – 0.2 (0.2–0.3)
1.7 8.2 4.8 SP398 0.4 (0.1–2.3) 0.1 (0.1–0.2) 17 (10–24) 0.2 (0.2–0.2)
h2AR+GsaS
12.1 5.0 0.4 SP161 3.8 (1.2–12) 0.2 (0.2–0.3) 13 (8–19) 0.2 (0.2–0.2)
9.5 6.4 0.7 SP175 0.1 (0.01–1.0) 0.2 (0.1–0.2) 12 (7–17) 0.2 (0.2–0.2)
8.7 6.5 0.8 SP410 0.1 (0.04–0.4) 0.2 (0.2–0.3) 14 (11–17) 0.3 (0.2–0.3)
1.1 2.3 2.1 SP427 0.5 (0.2–1.0) 0.2 (0.1–0.2) 23 (19–27) 0.2 (0.2–0.2)
h2AR+GsaL
14.6 9.7 0.7 SP411 – 0.2 (0.1–0.2) – 0.2 (0.1–0.2)
13.8 10.7 0.8 SP369 – 0.3 (0.3–0.4) – 0.4 (0.3–0.4)
12.8 10.8 0.8 SP428 – 0.1 (0.1–0.1) – 0.2 (0.1–0.2)
0.9 9.7 11 SP431 0.3 (0.1–1.0) 0.2 (0.1–0.3) 19 (15–24) 0.2 (0.2–0.2)
Agonist binding was determined as described in Materials and methods. The data shown in Figs. 2 and 3 were analyzed by nonlinear regression for best fit to
monophasic or biphasic competition isotherms (one-site or two-site competition). The table also contains the nonlinear regression analysis of additional
membrane preparations not shown in Figs. 2 and 3. G-protein/receptor ratios (G/R ratios) were calculated by dividing the Gsa expression level by the receptor
expression level. Data shown are the means from three to four independent experiments performed in triplicates. Numbers in parentheses represent the 95%
confidence intervals. Kh and Kl designate the dissociation constants for the high- and low-affinity states of the receptors, Rh (%) the percentage of high-affinity
binding sites and KGTPgS the dissociation constant for the low-affinity state of the D1R and h2AR in the presence of 10 AM GTPgS.
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GTPgS-stimulated AC activity in membranes expressing
Gaolf (Fig. 4B–C). These data support the view that even
GsaS/L-GDP is quite efficient at activating AC [54]. In
membranes expressing GsaS and GsaL, GTPgS activated
AC with similar potency (EC50 GsaS, 16 nM; 95% confi-
dence interval, 8–34 nM) (EC50 GsaL, 31 nM; 95% confi-
dence interval, 27–34 nM) as in the other membranes.
However, the maximum GTPgS-stimulated AC activities
in membranes expressing GsaS and GsaL were f 3–3.5-
fold higher than in membranes expressing Gaolf. Taken
together, these data indicate that Gaolf is considerably less
efficient at activating AC than GsaS and GsaL, i.e. Gaolf just
exceeds the efficacy of the endogenous Gsa-like proteins of
the insect cells.
Numerous receptors exhibit constitutive activity [55,56].
Constitutive receptor activity increases GDP/GTP exchange
at G-proteins in an agonist-independent manner. According-
ly, constitutive activity of Gs-coupled receptors results in
strong stimulatory effects of GTP on basal AC activity[38,57–59]. However, GTP was essentially devoid of stim-
ulatory effects on AC in membranes from uninfected cells
and membranes from cells expressing mammalian Gsa
proteins (Fig. 4). These data indicate that Sf9 cells do not
endogenously express sufficiently high levels of constitu-
tively active receptors that couple to Gsa-like proteins or
mammalian Gs-proteins. Thus, Sf9 membranes provide an
excellent background for the analysis of constitutively
active mammalian receptors.
3.6. Analysis of AC activity in the presence of receptors
Fig. 5 shows representative concentration/response
curves for the stimulatory effects of GTP on AC activity
in the absence and presence of agonist and inverse agonist in
Sf9 membranes expressing the D1R or h2AR alone and
together with mammalian Gsa proteins. Table 4 summarizes
the AC activities in Sf9 membranes expressing the h2AR
and D1R with Gsa splice variants at different Gsa/receptor
ratios (f 0.4–2.0 for GsaS and f 0.7–12 for GsaL). In
Table 2
GTPgS binding in Sf9 membranes expressing the D1R and h2AR, respectively, and various Gsa proteins at different G-protein/receptor ratios
Constructs
(receptor
level in
pmol/mg)
Gsa
(pmol/mg)
G/R
ratio
Membrane
preparation
GTPgS
bound
(basal)
(pmol/mg)
GTPgS
bound
( + inv. ago.)
(pmol/mg)
GTPgS
bound
( + ago.)
(pmol/mg)
GTPgS
bound
(Dinv. ago.)
(pmol/mg)
GTPgS
bound
(Dago.)
(pmol/mg)
GTPgS
bound
(Dtotal)
(pmol/mg)
Coupling
factor
Receptor-
activated
Gsa (percent
of total)
D1R +Gaolf
4.9 10.5 2.1 SP384 0.40F 0.04 0.35F 0.03 0.47F 0.03  0.05 0.07 0.12 0.024 1.1
1.5 8.9 5.9 SP395 1.65F 0.08 1.78F 0.18 2.00F 0.19 0.13 0.35 0.35 0.233 3.9
D1R +GsaS
13.5 8.8 0.7 SP474 1.91F 0.14 1.56F 0.11 2.38F 0.13  0.35 0.47 0.82 0.061 9.3
11.8 10.5 0.9 SP475 1.74F 0.27 1.30F 0.18 1.97F 0.25  0.45 0.23 0.67 0.057 6.4
6.3 11.9 1.9 SP476 1.63F 0.21 1.50F 0.22 2.30F 0.28  0.13 0.68 0.81 0.129 6.8
D1R +GsaL
10.9 10.7 1.0 SP366 0.57F 0.22 0.61F 0.01 0.84F 0.06  0.04 0.27 0.27 0.025 2.5
h2ARGaolf
19.8 3.0 0.2 SP429 1.41F 0.19 1.38F 0.10 1.54F 0.07  0.03 0.13 0.16 0.008 5.3
h2AR+GsaS
4.4 10.4 2.4 SP368 1.25F 0.09 1.25F 0.07 1.57F 0.10 0.00 0.32 0.32 0.073 3.1
12.1 5.0 0.4 SP161 1.51F 0.19 1.45F 0.08 1.93F 0.12  0.06 0.42 0.48 0.040 9.6
1.1 2.3 2.1 SP427 0.95F 0.19 0.91F 0.25 1.17F 0.28  0.04 0.22 0.26 0.236 11.3
h2AR+GsaL
13.8 10.7 0.8 SP369 1.22F 0.18 1.19F 0.04 1.45F 0.21  0.03 0.23 0.26 0.019 2.4
12.8 10.8 0.8 SP428 0.91F 0.06 0.82F 0.08 1.05F 0.12  0.09 0.14 0.23 0.018 2.1
0.9 9.7 11 SP431 0.50F 0.23 0.46F 0.06 0.64F 0.16  0.04 0.15 0.19 0.211 2.0
h2AR
12.2 n.a. n.a. SP46 0.78F 0.19 0.77F 0.10 0.93F 0.08  0.01 0.17 0.18 n.a. n.a.
GTPgS binding in Sf9 membranes expressing various proteins was determined as described in Materials and methods. G-protein/receptor ratios (G/R ratios)
were calculated by dividing the Gsa expression level by the receptor expression level. Reaction mixtures contained 1 nM [
35S]GTPgS, 9 nM unlabeled GTPgS
and 1 AMGDP in the presence of solvent (basal), 1 AM chlorpromazine/1 AM ICI 118,551 ( + inv. ago.) or 10 AM dopamine/10 AM ( )-isoproterenol ( + ago.).
Data shown are the means of three independent experiments performed in triplicates. The differences between basal GTPgS binding and GTPgS binding in the
presence of inverse agonist (Dinv. ago.), the differences between basal GTPgS binding and GTPgS binding in the presence of agonist (Dago.) and the
maximum receptor-regulated GTPgS binding (Dtotal) were calculated. The coupling factor was calculated by dividing the maximum receptor-regulated GTPgS
binding by the receptor expression level. The percentage of receptor-activated G-proteins was calculated by dividing the maximum receptor-regulated GTPgS
binding by the Gsa expression level. n.a., not applicable.
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only a small stimulatory effect on basal AC activity (Fig. 5A
and E). Accordingly, the effects of the inverse agonists were
small. However, agonist substantially increased AC activity
in membranes expressing D1R and h2AR, reflecting the
coupling of those receptors to Gsa-like proteins. In mem-
branes co-expressing the D1R or h2AR with Gaolf, the
maximum agonist-stimulated AC activities did not exceedTable 3
GTPase activity in Sf9 membranes expressing the D1R and h2AR, respectively, a
Constructs Receptor
(pmol/mg)
Gsa
(pmol/mg)
G/R
ratio
Membrane
preparation
GTPase
(basal)
(pmol/m
D1R +Gaolf 19.9 7.5 0.3 SP364 0.21F
D1R+GsaS 4.2 10.2 2.4 SP365 0.52F
D1R+GsaL 10.9 10.7 1.0 SP366 0.65F
h2AR+Gaolf 17.5 6.5 0.4 SP367 0.80F
h2AR+GsaS 4.4 10.4 2.4 SP368 0.79F
h2AR+GsaL 13.8 10.7 0.8 SP369 1.47F
h2AR 7.5 n.a. n.a. SP48 0.80F
GTPase activity in Sf9 membranes expressing various proteins was determined as
were calculated by dividing the Gsa expression level by the receptor expression
unlabeled GTP in the presence of solvent (basal) or 10 AM dopamine/10 AM
independent experiments for each membrane preparation performed in quadruplic
and the absolute agonist-stimulation of GTP hydrolysis (Dago.) were calculated.the AC activities in the presence of receptors alone (com-
pare Fig. 5A with B and Fig. 5E with F). Similarly low AC
activities were obtained when additional membranes co-
expressing receptors and Gaolf (SP367, SP378, SP384,
SP395, SP398 and SP426) were analyzed (data not shown).
In contrast, the AC activities in membranes co-expressing
receptors and Gsa splice variants exceeded the AC activities
determined with receptors alone (Fig. 5 and Table 4). Thesend various Gsa proteins
activity
g/min)
GTPase
activity ( + ago.)
(pmol/mg/min)
Agonist-stimulation
(percent of basal)
GTPase
activity (Dago.)
(pmol/mg/min)
0.05 0.38F 04 182 0.17
0.11 1.37F 0.21 164 0.85
0.05 1.12F 0.09 173 0.47
0.10 1.10F 0.15 138 0.30
0.09 1.54F 0.10 194 0.75
0.09 2.01F 0.12 112 0.54
0.08 1.10F 0.08 138 0.30
described in Materials and methods. G-protein receptor ratios (G/R ratios)
level. Reaction mixtures contained 0.2–0.5 ACi [g-32P]GTP and 100 nM
( )-isoproterenol ( + ago.). Data shown are the means of three to four
ates. The relative agonist-stimulation of GTP hydrolysis (percent of basal)
Fig. 4. Effects of GTP and GTPgS on AC activity in Sf9 membranes expressing various G-proteins. AC activity in membranes from uninfected Sf9 cells (A),
Sf9 membranes expressing Gaolf (10.5F 2.0 pmol/mg) (B), Sf9 membranes expressing GsaS (5.9F 0.3 pmol/mg) (C) and Sf9 membranes expressing GsaL
(10.1F1.6 pmol/mg) (D) was determined as described in Materials and methods. Reaction mixtures contained GTPgS (n) or GTP (5) at the concentrations
indicated on the abscissa. Data shown are the meansF S.D. of three to four experiments performed in duplicates with three to five membrane preparations.
‘‘ 10’’ designates the absence of guanine nucleotide.
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of receptors (Fig. 4).
In Sf9 membranes co-expressing the D1R or h2AR with
GsaS or GsaL, GTP exhibited profound stimulatory effects
on basal AC activity (Fig. 5C, D, G and H) (Table 4).
Moreover, the inverse D1R agonist, chlorpromazine [60],
and the inverse h2AR agonist, ICI 118,551 [38,59,61],Fig. 5. Effects of GTP, agonist and inverse agonist on AC activity in Sf9 membrane
membranes expressing various proteins was determined as described in Materi
indicated on the abscissa. Experiments shown in panels A–D were conducted
chlorpromazine (o). Experiments shown in panels E–H were conducted in the pr
118,551 (o). Data shown are the meansF S.D. of five to ten experiments perform
mg. The expression level of h2AR (SP602) (E) was 23.9 pmol/mg. Receptor- and G
Table 4. ‘‘ 8’’ designates the absence of GTP.reduced the stimulatory effects of GTP on basal AC activity.
Furthermore, GTP did not substantially increase AC activity
in Sf9 membranes expressing Gsa splice variants alone (Fig.
4C and D). These data indicate that the stimulatory effects
of GTP on AC activity in the co-expression membranes are
attributable to constitutive activity of the D1R and h2AR.
However, chlorpromazine and ICI 118,551 inhibited thes expressing the D1R or h2AR with various Gsa proteins. AC activity in Sf9
als and methods. Reaction mixtures contained GTP at the concentrations
in the presence of solvent (control) (E), 10 AM dopamine (.) or 1 AM
esence of solvent (control) (E), 10 AM ( )-isoproterenol (.) or 1 AM ICI
ed in duplicates. The expression level of D1R (SP608) (A) was 24.8 pmol/
sa expression levels of the other membrane preparations are summarized in
Table 4
AC activation in Sf9 membranes expressing the D1R and h2AR, respectively, and various Gsa proteins at different G-protein/receptor ratios
Constructs
(receptor level
in pmol/mg)
Gsa
(pmol/mg)
G/R
ratio
Membrane
preparation
GTP,  agonist
(pmol/mg/min)
+GTP,  agonist
(pmol/mg/min)
Const. act.
(percent
of total)
+GTP, + agonist
(pmol/mg/min)
Ago. - stim.
(percent of
control)
+GTPgS
(pmol/mg/min)
D1R +GsaS
13.5 8.8 0.65 SP474 10.9F 0.7 (8) 28.2F 3.4 (6) 83.2 31.7F 3.2 (6) 113 34.6F 1.1 (6)
11.8 10.5 0.89 SP475 10.3F 1.9 (12) 26.4F 6.9 (12) 77.8 31.0F 6.5 (14) 117 34.2F 2.5 (6)
6.3 11.9 1.89 SP476 10.1F1.7 (8) 23.5F 4.6 (6) 56.8 33.7F 4.4 (6) 144 39.1F 2.9 (6)
5.7 4.0 0.70 SP339 6.4F 0.7 (13) 26.9F 2.2 (9) 62.1 39.4F 4.9 (9) 147 49.4F 4.8 (4)
D1R +GsaL
10.9 10.7 0.98 SP366 3.5F 0.8 (12) 13.8F 2.0 (8) 79.2 16.5F 3.0 (8) 120 26.8F 4.5 (8)
3.8 11.5 3.03 SP380 2.4F 0.7 (10) 7.4F 2.1 (6) 76.9 8.9F 2.6 (6) 119 16.1F 3.1 (8)
2.2 11.5 5.23 SP386 2.5F 0.8 (14) 9.4F 3.4 (12) 73.4 11.9F 3.8 (13) 126 15.6F 3.8 (8)
h2AR+GsaS
12.1 5.0 0.41 SP161 22.5F 9 (4) 54.4F 20.3 (4) 60.4 75.3F 18.1 (4) 138 77.1F 7.7 (4)
9.5 6.4 0.67 SP175 8.0F 2.3 (7) 22.1F 6.4 (7) 47.3 37.8F 9.7 (7) 171 32.3F 1.3 (4)
8.7 6.5 0.75 SP410 6.6F 1.7 (10) 18.4F 5.6 (6) 46.5 32.0F 8.7 (6) 174 32.5F 2.1 (4)
1.1 2.3 2.09 SP427 2.5F 1.6 (6) 7.7F 1.6 (5) 36.1 14.4F 1.8 (6) 187 18.7F 0.1 (2)
h2AR+GsaL
14.6 9.7 0.66 SP411 8.4F 1.9 (16) 26.5F 9.5 (10) 50.8 44.0F 15.5 (10) 166 37.6F 7.6 (8)
13.8 10.7 0.78 SP369 6.5F 1.9 (12) 21.1F 7.1 (8) 57.7 31.8F 12.3 (7) 151 31.4F 8.2 (8)
12.8 10.8 0.85 SP428 4.1F1.7 (10) 9.8F 2.2 (7) 37.0 19.5F 5.6 (8) 198 22.2F 9.6 (4)
0.9 9.7 10.8 SP431 3.1F 0.7 (8) 9.5F 3.4 (6) 46.7 16.8F 6.0 (6) 176 11.9F 0.3 (2)
AC activity in Sf9 membranes expressing various proteins was determined as described in Materials and methods. Reaction mixtures contained no addition
(GTP,  agonist), 100 AM GTP ( +GTP,  agonist), 100 AM GTP+ 10 AM dopamine or 10 AM ( )-isoproterenol ( +GTP, + agonist) and 10 AM GTPgS
( +GTPgS), respectively. The number of independent experiments (each performed in duplicates) is shown in parentheses after each data set. Data shown are
the meansF S.D. of the individual experiments. G-protein/receptor ratios (G/R ratios) were calculated by dividing the Gsa expression level by the receptor
expression level. The constitutive activities of the D1R and h2AR (const. act. (percent of total)) were calculated by dividing the difference of the absolute AC
activities in the presence of GTP and absence of agonist ( +GTP,  agonist) and the AC activities in the absence of GTP and agonist (GTP,  agonist) by
the difference of the absolute AC activities in the presence of GTP and agonist ( +GTP, + agonist) and the AC activities in the absence of GTP and agonist
(GTP,  agonist). The relative stimulatory effects of agonists on AC activity (ago. - stim. (%)) were calculated by dividing the AC activity in the presence of
GTP and agonist ( +GTP, + agonist) by the AC activity in the presence of GTP and absence of agonist ( +GTP,  agonist).
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that these ligands are partial inverse agonists at the D1R and
h2AR, respectively. In view of these data, the most accurate
measure of constitutive receptor activity in our system is the
stimulatory effect of GTP on basal AC activity relative to
the combined stimulatory effects of GTP plus agonist. The
constitutive activity of the D1R coupled to Gsa splice
variants amounted to 57–83% of total receptor activity in
various membrane preparations, whereas the corresponding
values for the h2AR were generally lower (36–60%) (Table
4). In agreement with these data, the relative stimulatory
effects of agonist were larger in membranes expressing the
h2AR (38–98%) than in membranes expressing the D1R
(13–47%). In the co-expression system, we did not observe
a difference in apparent constitutive activity of the h2AR
coupled to Gsa splice variants (Fig. 5G and H), whereas the
h2AR fused to GsaL exhibits higher constitutive activity
than the h2AR fused to GsaS [34,38].
In studies on the coupling of the h2AR to Gsa-like
proteins, a linear relation between receptor expression level
and AC activity was observed [58]. In contrast, the highest
agonist- and GTPgS-stimulated AC activities regarding
D1R/GsaS couples were observed with SP339 that exhibited
the lowest absolute receptor and Gsa level. In addition,
reduction of the h2AR expression level by 15-fold (compare
SP411 with SP431) did not result in a proportional decreasein AC activities. Similarly, a fivefold decrease in D1R
expression level (compare SP366 with SP386) was only
accompanied by moderate reductions of agonist- and
GTPgS-stimulated AC activities.4. Discussion
4.1. Inefficiency of Gaolf at activating AC
Previous studies from our laboratory using h2AR-Gsa
fusion proteins uncovered differences between GsaL, GsaS
and Gaolf in terms of their efficacy at activating AC [34,37–
39]. In view of concerns regarding the physiological rele-
vance of fusion proteins [31,32,40], the aim of our present
study was to dissect differences between Gsa isoforms using
nonfused Gsa proteins. Immunoblotting studies showed that
GsaS, GsaL and Gaolf were all expressed in Sf9 membranes
(Fig. 1). As predicted from the h2AR-Gsa fusion protein
studies, nonfused Gaolf was much less efficient at activating
AC than Gsa splice variants both in the absence and
presence of receptors (Figs. 3 and 4). When expressed in
Gsa-deficient S49 cyc
 lymphoma cells, Gaolf was also less
efficient than GsaL and GsaS at activating AC [28]. Thus,
with regard to the inefficiency of Gaolf at activating AC, the
data obtained in various expression systems are consistent.
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structural differences between the a-helical domains of GsaS
and Gaolf contribute to the differences in AC activation
between these Gsa isoforms [8,62].
4.2. Analysis of constitutive receptor activity
The h2AR is the most extensively studied receptor
exhibiting constitutive activity [56]. Our present study
corroborates the notion that the h2AR possesses substantial
constitutive activity (Fig. 5 and Table 4). The co-expression
system allows for sensitive analysis of constitutive receptor
activity (Figs. 4 and 5 and Table 4). Using this system and
comparing multiple membrane preparations, we found that
the D1R possesses an even higher constitutive activity than
the h2AR. These data point to the importance of agonist-
independent dopaminergic signal transduction for the proper
function of neurons. The incomplete inhibition of GTP-
dependent AC activation by ICI 118,551 and chlorproma-
zine demonstrates that these ligands are only partial inverse
agonists at the h2AR and D1R, respectively. Taken together,
the system devised in this study is useful to compare
constitutive activity of various Gs-coupled receptors and to
assess the inverse agonistic efficacy of compounds.
4.3. Limitations of the co-expression approach
We conducted a large body of work to dissect differences
between the three Gsa proteins, analyzing multiple param-
eters repeatedly in numerous membrane preparations. How-
ever, overall, the results of our study were very
disappointing. Regardless of whether ternary complex for-
mation (Figs. 2 and 3 and Table 1), GTPgS binding (Table
2), GTP hydrolysis (Table 3) and AC activity (Figs. 4 and 5
and Table 4) were analyzed, no differences between Gaolf
and Gsa splice variants, between GsaS and GsaL and Gsa-
coupling of the h2AR and D1R except for the few differ-
ences discussed above were detected. We also noted a lack
of relation between expression level and functional activity
of Gsa-proteins in the various assays, rendering data inter-
pretation very difficult if not impossible. Our results are
reminiscent to the results of previous expression studies
using S49 cyc lymphoma cells [28,29]. Moreover, even
reconstitution studies with purified receptors and G-proteins
did not uncover differences between GsaS and GsaL [63,64].
Several factors that are not mutually exclusive may have
contributed to the largely negative outcome of our study.
First, we quantitated Gsa protein expression in immunoblot-
ting studies using h2AR-Gsa fusion proteins as standard
(Fig. 1). However, such studies do not provide information
about the functional integrity of the expressed G-proteins.
The GTPgS saturation binding studies showed that only a
minority of the expressed Gsa proteins participated in
receptor coupling, but we cannot distinguish whether this
is because of inefficient receptor-activation of Gsa proteins
or functional inactivity of Gsa proteins (Table 2). Second,one could explain our data by differential compartmentation
of receptors, Gsa proteins and AC in specific membrane
microcompartments [65–67]. In fact, it has already been
shown that the glucagon receptor, h2AR and Gsa splice
variants are differentially compartmentalized in the regen-
erating rat liver [68]. Future studies will have to assess the
specific localization of receptors and Gsa proteins in Sf9 cell
membranes, for example by using fluorescent dye-tagged
proteins [69]. It is possible that even in reconstitution
systems with purified proteins, receptors and G-proteins
do not interact freely with each other. Third, it is well
known that Gsa splice variants differentially distribute
between membrane and cytosol in various systems
[19,70,71]. Regardless of which of the three explanations
is correct, the co-expression approach using non-modified
Gsa proteins, although apparently closer to the physiological
situation than fusion proteins or tethered Gsa proteins, does
not provide a sensitive approach to dissect biochemical
differences between Gsa proteins.
4.4. Comparison of the co-expression and fusion protein
approach
In a previous study we showed that signaling in the
h2AR-GsaL fusion protein in terms of ternary complex
formation, GTPgS binding, GTP hydrolysis and AC acti-
vation was much more efficient than in the h2AR/GsaL co-
expression system [43]. This conclusion can now be ex-
tended to the other two Gsa proteins, GsaS and Gaolf (Tables
1–4) [37]. Fusion proteins are particularly more sensitive
than co-expression systems with respect to GTPgS binding
and GTP hydrolysis. Most likely, the high signaling effi-
ciency in h2AR-Gsa fusion proteins is the result of tight
membrane-tethering of Gsa [33]. The similarities between
Gsa isoforms in terms of signaling in the fused versus
nonfused state indicate that the fundamental mechanisms
governing receptor/G-protein coupling are similar for the
three Gsa isoforms.
The fusion protein approach allowed us to dissect mul-
tiple biochemical differences between Gsa isoforms, includ-
ing kinetics of GTPgS binding and GTP hydrolysis, GDP-
affinity, efficacy at activating AC and their ability to confer
constitutive activity to the h2AR [34,37,38]. The only
biochemical difference between nonfused Gsa splice var-
iants that we could unmask in the present study concerns the
lower efficacy of Gaolf at activating AC relative to Gsa
splice variants. This difference was observed in the fusion
proteins as well. In conclusion, it is much easier to dissect
differences between Gsa isoforms using h2AR-Gsa fusion
proteins than nonfused Gsa isoforms.Acknowledgements
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